David Klein, Kevin Mausert, Richard Campbell, Tobias Schad, Kate Kennedy
January 24, 2026
Kirkland Represents Vera Whole Health on Combination with Castlight Health
1 min
AI-made summary
- Kirkland & Ellis represented Vera Whole Health, Inc
- in its combination with Castlight Health, Inc
- for approximately $370 million
- Clayton, Dubilier & Rice, Vera's majority equity holder, committed up to $338 million to support the deal, while Anthem, Inc
- will also invest in the combined company
- Following the transaction, Castlight will become privately held
- The deal is subject to customary closing conditions and is expected to close in the first quarter of 2022.
Kirkland & Ellis advised Vera Whole Health, Inc. ("Vera"), a pioneer in advanced primary care, on its combination with Castlight Health, Inc. (NYSE: CSLT), a leading healthcare data and navigation company, for approximately $370 million. Clayton, Dubilier & Rice, Vera's majority equity holder, has committed to invest up to $338 million to support the combination, and Anthem, Inc., a leading health company and long-time strategic customer of Castlight, will make an investment in the combined company. Upon completion of the transaction, Castlight will become a privately held company. The transaction is subject to customary closing conditions and is expected to be completed in the first quarter of 2022. Read Vera's press release
The Kirkland team was led by corporate partners David Klein, Kevin Mausert, Richard Campbell and Tobias Schad and associate Kate Kennedy.
Article Author
David Klein, Kevin Mausert, Richard Campbell, Tobias Schad, Kate Kennedy
The Sponsor